Annual report pursuant to Section 13 and 15(d)

Supplemental Cash Flow Information (Details)

v2.4.0.6
Supplemental Cash Flow Information (Details) (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Summary of supplemental cash flow information      
Interest paid $ 945 $ 726 $ 4,386
Income taxes paid, net 575 338 235
Shares issued upon the conversion of:      
Series D Preferred Stock   1,742  
Common Stock warrants, net exercised 7 1,155  
Exakta OPKO [Member]
     
Issuance of capital stock to acquire:      
Issuance of capital stock     1,999
OPKO Diagnostics [Member]
     
Issuance of capital stock to acquire:      
Issuance of capital stock   22,452  
Fine Tech [Member]
     
Issuance of capital stock to acquire:      
Issuance of capital stock   17,717  
Farmadiet [Member]
     
Issuance of capital stock to acquire:      
Issuance of capital stock 805    
OURLab [Member]
     
Issuance of capital stock to acquire:      
Issuance of capital stock $ 32,888